Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 13, 2000

View Archived Issues

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Bristol-Myers Squibb and ICAgen to continue collaboration for atrial fibrillation

Buccal formulation of insulin will be developed by Lilly and Generex

Lupus therapy candidate granted orphan drug designation

BASF grants exclusive licenses for oncolytic compounds to Ilex

Low-dose nifekalant safely suppresses ventricular arrhythmias following AMI

Full, selective 5-HT1A antagonist characterized as having potential in depression, smoking cessation

SDZ-RAD continues to shine as a potential agent for transplantation

FR-167653 exerts beneficial effects in rat model of ischemia/reperfusion liver injury

NO donor FK-409 protects against ischemia/reperfusion injury of small intestine

HGS advances clinical development of novel protein

Antihypertensive activity demonstrated for new vasopressin receptor antagonists in rats

SRI presents novel steroid mimics useful for breast cancer

Pyrazoles as selective CB2 receptor modulators patented by SmithKline Beecham

Gaucher's disease treatment shows continued efficacy after 18 months

Synthesis and activity of novel PTK inhibitors reported by U.S. university researchers

Long-term, once-a-day efficacy demonstrated by HAART regimen including Coviracil

Canadian lab designs 5-ht6 receptor antagonists for schizophrenia

Crohn's disease therapy effective and safe in phase II trial

New antibiotics emerging from Pfizer R&D

Priority review granted to Femara as first-line breast cancer therapy

Several series of inhibitors of VLA-4-mediated cell adhesion from Elan covered by patents

Phase I clinical trials of Xcytrin begin for treatment of NSCLC and glioblastoma multiforme

C5 inhibitor receives fast track status for use in cardiopulmonary bypass

NCI sponsors additional phase II studies of Prostvac VF vaccine

DNA vaccine encoding C3d enhances immune response to influenza

Researchers uncover protein key to the development of Alzheimer's

Metformin completely reverses fatty liver in mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...